·

Company Name Changed
From Watson R&D Co., Ltd. to nanovax Co., Ltd.

·

Technology Transferred
for PCV2 VLP Vaccine to CAVAC Co., Ltd

·

MOU Signed for Joint Development of Animal Infectious Disease Vaccine Technology
CAVAC Co., Ltd.

·

Series A Funding Secured: KRW 2 Billion
Investor: DVP, IBK

·

Selected for the Scale-Up TIPS Program (SME Technology Development Project)

·

Selected for High-Risk Animal Infectious Disease Prevention Technology Development Project

·

Certified as a Technology-Innovative SME (Inno-Biz)

·

Certified as a Specialized Company in Materials, Parts, and Equipment

·

Selected for the Market-Oriented SME Technology Innovation Development Program

·

Relocated to Its owned Headquarters at Ace High-End Tower, Byeollae-dong, Namyangju

·

Selection for the Startup Growth Technology Development Project (Strategic Type)

·

Early-Stage VC Funding Secured: KRW 400 Million
Investor: Evergreen Investment Partners LLC

·

Selected as a TIPS (Tech Incubator Program for Startup) Company, Led by Private Investment

·

Selected for the Startup Leap Package Program

·

Establishment of Watson R&D Co., Ltd.

·

Establishment of a Corporate Research Institute

·

Certified as a Venture Business

·

Selected for the Startup Growth Technology Development Program (Initial Step Track)